Identify high-quality drug leads and optimize clinical candidates using DNA-encoded library data and Chemomics to reduce risk in biotech and pharma discovery.
Drug Discovery AI Tools
Discover 25 Drug Discovery tools on AI Tech Suite, including X-Chem, BenevolentAI and Aitia Bio
Free
Freemium
Web
Android
iOS
New
Hiring
Explore the directory
Uncover new therapeutic insights and accelerate drug discovery with AI-driven life science intelligence designed for researchers and pharmaceutical teams.
Aitia Bio uses AI, multi-omic data, and Gemini Digital Twins to accelerate drug discovery and development, focusing on oncology and neurodegenerative diseases.
Aganitha AI is an in silico company that partners with biopharma, personal & homecare, and material sciences industries, leveraging AI to accelerate scientific R&D.
Accelerate small molecule drug discovery and tackle hard-to-drug targets using a clinical-stage AI platform designed for biotech and pharmaceutical researchers.
Identify new therapeutic indications for existing compounds using an AI-powered systems biology platform to reduce R&D costs and accelerate time-to-market.
AI-driven platform that accelerates the discovery of treatments for rare diseases.
Accelerate ALS drug discovery and target identification using deep generative models and multi-omics data analysis to find novel therapeutics for patients.
canSAR.ai is an integrated knowledge-base leveraging machine learning and AI for cancer drug discovery and translational research worldwide.
Identify novel therapeutic targets for hard-to-treat solid tumors by using an ML-powered transcriptomics platform to analyze single-cell RNA and stromal biology.
Help pharmaceutical researchers accelerate drug discovery and minimize clinical trial failure by mapping causal genetic links using AI-driven Mendelian randomization.
Design programmable protein interactions and discover next-generation proximity-based medicines using an integrated AI platform for biopharmaceutical research.
Accelerate drug discovery by integrating generative AI with automated robotics to design, synthesize, and test novel molecules in under two years for pharma teams.
Accelerate RNA drug discovery using a foundation model that predicts 3D structures with atomic precision to unlock previously inaccessible therapeutic targets.
Design superior therapeutic molecules and accelerate drug discovery using physics-based AI algorithms and high-throughput experimental feedback loops.
Accelerate drug discovery and vaccine development by leveraging AI to interpret complex genetic datasets and understand the fundamental language of human cells.
Accelerate functional genomics research and simulate complex gene regulatory networks using cross-species foundational AI models for in-silico cell engineering.
Extend healthy human lifespan and discover novel therapeutic targets using physics-informed AI models trained on over 100 million longitudinal medical records.
Optimize early-stage drug discovery for biotech researchers using an AI ecosystem that identifies cryptic binding sites and predicts over 80 ADMET endpoints.
Accelerate life sciences R&D using a foundational graph AI that unifies billions of biomedical data points to provide reliable, literature-backed insights.
Empower drug discovery teams to unlock difficult-to-drug targets and optimize lead candidates using quantum mechanical precision and trillion-scale generative AI.
Accelerate drug discovery using physics-based AI and high-throughput automation to design superior medicines and optimize therapeutic profiles for unmet patient needs.
Access and evaluate AI models for drug discovery using a comprehensive ecosystem of AI-ready datasets, curated benchmarks, and specialized Python libraries.
Accelerate drug discovery by generating novel, synthesizable small molecules optimized for potency and safety with a generative AI foundation model for R&D teams.
Genesis Therapeutics uses an advanced molecular AI platform (GEMS) to discover and design breakthrough medicines for challenging targets with unprecedented potency and selectivity.